AZN vs NVO
AstraZeneca PLC · Novo Nordisk A/S
Relative return (rebased to 100)
Key stats
| Metric | AZN | NVO |
|---|---|---|
| Price | $186.76 | $40.70 |
| Market Cap | $289.48B | $180.87B |
| P/E | 28.31 | — |
| P/B | 5.95 | — |
| P/S | 4.93 | — |
| ROE | 21.0% | — |
| Net Margin | 17.4% | — |
| Gross Margin | 81.9% | — |
| Revenue Growth | 8.6% | — |
| Dividend Yield | 1.68% | — |
| EPS | $6.60 | — |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.